首页> 美国卫生研究院文献>Journal of Arrhythmia >Study design of GENERAL (general practitioners and embolism prevention in NVAF patients treated with rivaroxaban: Real-life evidence): A multicenter prospective cohort study in primary care physicians to investigate the effectiveness and safety of rivaroxaban in Japanese patients with NVAF

【2h】

Study design of GENERAL (general practitioners and embolism prevention in NVAF patients treated with rivaroxaban: Real-life evidence): A multicenter prospective cohort study in primary care physicians to investigate the effectiveness and safety of rivaroxaban in Japanese patients with NVAF

机译：GENERAL的研究设计（利伐沙班治疗的NVAF患者的全科医生和栓塞预防：真实证据）：一项针对初级保健医师的多中心前瞻性队列研究旨在调查利伐沙班在日本NVAF患者中的有效性和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundRivaroxaban, a direct oral anticoagulant (DOAC), has become available for stroke prevention in patients with non-valular atrial fibrillation (NVAF). However, little is known about its effectiveness and safety when prescribed by general practitioners in real-life settings.

机译：背景：Rivaroxaban是一种直接口服抗凝剂（DOAC），已用于非瓣膜性房颤（NVAF）患者的中风预防。但是，当普通医生在现实生活中开处方时，对其有效性和安全性知之甚少。

著录项

期刊名称 Journal of Arrhythmia
作者
Kengo Kusano; Masaharu Akao; Hikari Tsuji; Kunihiko Matsui; Shinya Hiramitsu; Yutaka Hatori; Hironori Odakura;
展开▼
作者单位

展开▼
年(卷),期 2017(33),4
年度 2017
页码 297–301
总页数 5
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
Anticoagulants DOAC Non-valvular atrial fibrillation Stroke General practitioner;

机译：抗凝剂;DOAC;非瓣膜性房颤;中风;全科医生;

相似文献

外文文献
中文文献
专利

1. Study design of GENERAL (general practitioners and embolism prevention in NVAF patients treated with rivaroxaban: Real-life evidence): A multicenter prospective cohort study in primary care physicians to investigate the effectiveness and safety of rivaroxaban in Japanese patients with NVAF [J] . Kengo Kusano, Masaharu Akao, Hikari Tsuji, Journal of arrhythmia. . 2017,第4期

机译：一般的研究设计（普通人患者中的一般从业者和栓塞预防，所述Rivaroxaban治疗：现实实践证据）：初级护理医师的多中心前瞻性队列研究，探讨日本NVAF患者Rivaroxaban的有效性和安全性
2. Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation [J] . Ikeda Takanori, Atarashi Hirotsugu, Inoue Hiroshi, The Tohoku Journal of Experimental Medicine . 2016,第4期

机译：EXPAND研究的研究设计和基线特征：评价在全国范围内被诊断为非瓣膜性心房颤动的日本患者中，Xa抑制剂，利伐沙班预防中风和系统性栓塞的有效性和安全性
3. A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J’xactly Study) [J] . Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, Circulation journal . 2020,第11期

机译：多中心预期观察队列研究，探讨日本静脉血栓栓塞患者的rivaroxaban的有效性和安全性（J'Axact-Studication）
4. A Multicenter Prospective Cohort Study of Tonsillectomy and Steroid Therapy in Japanese Patients with IgA Nephropathy: A 5-Year Report [C] . Mariko Miyazaki, Osamu Hotta, Atsushi Komatsud International Symposium on IgA Nephropathy . 2007

机译：日本IGA肾病患者扁桃体切除术和类固醇治疗的多中心前瞻性队列研究：5年报告
5. Investigating Strategies To Improve Health Care Labor Market, Health Outcomes, Health Care Quality, And To Reduce Emergency Department Utilization And Costs: A Study Of The Effectiveness Of Family Friendly Policies, Patient-Centered Communication, And Enhanced Access To Care [D] . Tayou, Juliette Guemmegne. 2017

机译：调查策略，以改善卫生保健劳动力市场，卫生成果，卫生保健质量并减少急诊部门的使用和成本：家庭友好政策，以患者为中心的沟通和增强的就医机会的有效性研究
6. Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J’xactly) study [O] . Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, 2018

机译：日本注册的利伐沙班预防深静脉血栓形成和肺栓塞患者复发的有效性和安全性的设计和依据（Jxactly）研究
7. Study design of GENERAL (general practitioners and embolism prevention in NVAF patients treated with rivaroxaban: Real-life evidence): A multicenter prospective cohort study in primary care physicians to investigate the effectiveness and safety of rivaroxaban in Japanese patients with NVAF [O] . Kengo Kusano, MD, PhD, Masaharu Akao, MD, PhD, Hikari Tsuji, MD, 2017

机译：GENERaL的研究设计（使用利伐沙班治疗的NVaF患者的全科医生和栓塞预防：现实证据）：一项针对初级保健医生的多中心前瞻性队列研究，旨在研究利伐沙班在日本NVaF患者中的有效性和安全性

Study design of GENERAL (general practitioners and embolism prevention in NVAF patients treated with rivaroxaban: Real-life evidence): A multicenter prospective cohort study in primary care physicians to investigate the effectiveness and safety of rivaroxaban in Japanese patients with NVAF

摘要

著录项

相似文献

相关主题

期刊订阅